Abstract

Dolasetron Mesylate 20-mg/mL Injection

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2016 - Volume 20, Number 4

Page(s): 318

Download in electronic PDF format for $75
  • Dolasetron Mesylate 20-mg/mL Injection Page 1

Abstract

A formulation for preparing Dolasetron Mesylate 20-mg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • dolasetron mesylate
  • parenteral administration
  • compounded sterile products
  • aseptic compounding
  • nausea
  • vomiting
  • emesis
  • antiemetic
  • migraine

Related Categories

  • FORMULATIONS
  • GASTROENTEROLOGY
  • PARENTERALS
  • STERILE PREPARATIONS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2016
Pg. 318
Dolasetron Mesylate 20-mg/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Nov/Dec 2013
Pg. 503
Dihydroergotamine Mesylate 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2005
Pg. 475
Dolasetron 10-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2013
Pg. 498
Benztropine Mesylate 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2015
Pg. 69
Phentolamine Mesylate 5-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2015
Pg. 144
Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
May/Jun 2023
Pg. 223-229
Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Author(s): Allen Loyd V Jr
May/Jun 2022
Pg. 219-228
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Author(s): Allen Loyd V Jr
Jan/Feb 2014
Pg. 6-12
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Nov/Dec 2015
Pg. 491-500
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Author(s): Akers Michael J
Jul/Aug 2000
Pg. 250-251
Nausea and Vomiting in Hospice Patients
Author(s): Boomsma Diane
Mar/Apr 2003
Pg. 114-116
Autoclaves for the Sterilization of Compounded Parenteral Products
Author(s): Rahe Hank
Jul/Aug 2001
Pg. 246-253
Quality Assurance for Sterile Products
Author(s): Kastango Eric S, Douglass Kate
Mar/Apr 2013
Pg. 113-123
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities
Author(s): Zur Eyal
Nov/Dec 2022
Pg. 446-466
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 270-280
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Author(s): Logomasini Mark A, Stout Richard R, Ron Marcinkoski
Nov/Dec 2019
Pg. 447-452
Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators
Author(s): Mulder Kyle